Cystic fibrosis: a call for papers for ECFS 2022

Abstract

The Lancet Respiratory Medicine is now entering its sixth collaboration with the Journal of Cystic Fibrosis to co-host a research session at the European Cystic Fibrosis Society (ECFS) meeting. Last year to provide additional insight into both the peer review process and editorial decision making we were delighted to be joined by The European Respiratory Journal. I am pleased to announce that we will once again have a session involving the three journals at the 2022 ECFS meeting in June 8–11 in Rotterdam, The Netherlands. The aim of this cross-journal session is to provide an educational forum to discuss how the journals operate, and to disseminate the latest cutting-edge findings in this very active field. As previously, it will consist of selected research papers published in the journals, presented by the authors of those papers, with additional discussion from reviewers and editors on editorial processes and decisions made. The Lancet Respiratory Medicine is therefore looking for high-quality submissions in patients in the field of cystic fibrosis that will have an effect on management. We particularly welcome clinical trials. The journal offers a fast-track publication process. Please submit your paper through our online system mentioning this call for papers in your covering letter. The deadline for submissions is March 11, 2022. We look forward to reading your research that will help shape and improve patients' lives. To submit a paper to The Lancet Respiratory Medicine go to https://www.editorialmanager.com/THELANCETRM To submit a paper to The Lancet Respiratory Medicine go to https://www.editorialmanager.com/THELANCETRM